HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intravaginal misoprostol before induced abortion in nulliparous women].

Abstract
One hundred and twenty nine nulliparous requesting first trimester induced abortion between 7 and 12 weeks of amenorrhea (SA) were included in the study to evaluate the effectiveness and the side effects of misoprostol in the cervical ripening before aspiration. Three randomized groups of 43 patients received misoprostol 12 hours before induced abortion: group A received 200 mug inserted vaginally; group B received 400 mu g inserted vaginally and group C received 400 mu g orally. Cervical dilatation after treatment and maximal dilatation realized with Hegar dilatator were significantly higher in group B. The rate of partial abortion is significantly higher in group B. Tolerance is good in the three groups. No significant difference between the three groups related digestive disorders, pelvic pain and hyperthermia were noted. On the other hand the rate of metrorrhagia and hemorrhages more important than menstruation is higher in group B. Misoprostol 400 mu g inserted vaginally 12 hours before induced abortion in nulliparous women seem to be an effective, safe, practical and cheap method for cervical ripening before aspiration.
AuthorsB Schaub, P Fuhrer, D Sainte-Rose
JournalContraception, fertilite, sexualite (1992) (Contracept Fertil Sex) Vol. 24 Issue 1 Pg. 67-71 (Jan 1996) ISSN: 1165-1083 [Print] France
Vernacular TitleLe misoprostol par voie vaginale avant interruption volontaire de grossesse chez la nullipare.
PMID8932759 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Misoprostol
Topics
  • Abortifacient Agents, Nonsteroidal
  • Abortion, Induced (methods)
  • Administration, Intravaginal
  • Administration, Oral
  • Adult
  • Female
  • Humans
  • Misoprostol
  • Parity
  • Pregnancy
  • Pregnancy Trimester, First
  • Premedication (methods)
  • Prospective Studies
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: